![](https://news.europawire.eu/wp-content/uploads/2016/07/New-research-Acquisitions-buybacks-and-shareholder-driven-manoeuvre-threaten-public-access-to-breakthrough-drugs-144x144.jpg)
CAMBRIDGE, 28-Jul-2016 — /EuropaWire/ — An analysis of a new drug’s journey to market, published today in the BMJ, shines a light on financial practices that see some major pharmaceutical companies relying on a cycle of acquisitions, profits from high … Read the full press release